Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes

BACKGROUND: To investigate the clinical characteristics, treatments and outcomes of patients with myasthenia gravis with antibodies to muscle-specific tyrosine kinase (MuSK-MG). METHODS: We retrospectively reviewed the cases of 21 patients with confirmed MuSK-MG between January 2012 and January 2020...

Description complète

Détails bibliographiques
Auteurs principaux: Huang, Qi, Li, Feng, Zhao, Song
Format: Online Article Texte
Langue:English
Publié: BioMed Central 2022
Sujets:
Research
Accès en ligne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895578/
https://www.ncbi.nlm.nih.gov/pubmed/35246057
http://dx.doi.org/10.1186/s12883-022-02593-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895578/
https://www.ncbi.nlm.nih.gov/pubmed/35246057
http://dx.doi.org/10.1186/s12883-022-02593-6

Documents similaires